The plaintiff's claim was dismissed (the plaintiff's rights were invalidated). This is the 323rd case to have been declared "invalid" by the Intellectual Property High Court.
The plaintiff's claim was dismissed (the plaintiff's rights were invalidated).
This is the 323rd case to have been declared "invalid" by the Intellectual Property High Court.
https://docs.google.com/spreadsheets/d/1MDOW2-9n2HazyR4kgz0ajcCUwdB9Me02/edit?usp=sharing&ouid=103290795915107156428&rtpof=true&sd=true
Novo Nordisk Healthcare AG, the patent holder, lost an invalidation trial (Invalidation 2015-800114) filed by Laboratoire Français du ..., which is believed to be an interested party, and the Japan Patent Office ruled that "the patent for the invention related to claims 1 to 17 of Patent No. 4874806 is invalid."
The examiner of the Japan Patent Office cited "Exhibit 1" (document), "Exhibit 2" (document), and "Exhibit 3" (document) presented by the plaintiff as the basis for his decision.
During the examination stage at the Japan Patent Office, the examiner found "Exhibit 3" (document) among the above Exhibits A and presented it to the applicant.
However, this "Exhibit 3" (document) is listed as "X Document" in the "International Search Report" and is written by a Japanese author.
And he did not find the other two documents ("Exhibit 1" (document) and "Exhibit 2" (document)) and presented different documents to the applicant.
Here again, the weak research ability of the examiner of the Japan Patent Office is proven.
And the patent owner, Novo Nordisk Healthcare AG, appealed to the Intellectual Property High Court against the decision of the examiner of the Japan Patent Office to declare the patent "invalid", but the claim was dismissed as mentioned above.
In other words, the content of the decision of the Intellectual Property High Court was almost the same as the decision of the Japan Patent Office, which "dismissed the plaintiff's claim."
Even so, it seems that the Japan Patent Office's research ability into "foreign technical literature" at the examination stage is weak.
Perhaps it is due to a lack of language skills. It is not acceptable to grant a patent based on a careless search by an examiner at the examination stage of the Japan Patent Office.
Therefore, I believe that the Japan Patent Office should not have granted a patent to Novo Nordisk Healthcare AG's application in the first place.
（ハッシュタグ）
#INPIT #JPlatPat #note #生成AI #OpenAI #Claude #深層学習 #仕事 #ディープラーニング #ビジネス #ビジネススキル #ビジネスモデル #ビジネスチャンス #知財 #知財戦略 #知財塾 #知的財産 #知的財産権 #知的財産高等裁判所 #特許 #特許調査 #特許法 #特許庁 #特許事務所 #特許分類 #特許検索 #特許分析 #特許情報 #特許権者 #特許無効審判 #専利 #分類付与 #先行技術調査 #無効資料調査 #侵害調査 #侵害予防調査 #パテント #発明 #発明塾 #べらぼう #検索論理式 #審査官 #審判官 #AI #AIの活かし方 #AI画像生成 #IT #ITエンジニア #IT業界 #IT企業 #ITベンチャー #IT化 #IT系 #ITリテラシー #ITツール #DX #DX化 #DX推進 #DX人材 #DX事例 #DXリテラシー #Patent #ChatGPT #GPT #チャットGPT #ChatGPT4 #Gemini #Threads #bing #bingAI #VertexAI #一月万冊 #裁判所 #出願情報 #東京地方裁判所 #IPランドスケープ #JPO #USPTO #KIPO #EPO #知財ソリューション #知的財産戦略 #知財経営戦略 #知財情報 #知財業務 #知財活動 #知財部 #知財実務 #知財実務者 #知財担当者 #知財サービス #知財業界